✦ LIBER ✦

Moclobemide treatment of resistant depression in a patient with vascular dementia

✍ Scribed by Yoram Barak; Hanna Suholitsky; Shlomo Noy

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 198 KB
Volume: 11
Category: Article
ISSN: 0885-6222
DOI: 10.1002/(sici)1099-1077(199601)11:1<67::aid-hup740>3.0.co;2-8

No coin nor oath required. For personal study only.

✦ Synopsis

Patients suffering from dementia exhibit depressive symptoms in up to 86 per cent of cases. Syndromes meeting the criteria for major depression are more likely to respond to pharmacological therapy. Increased activity of M A 0 found in demented subjects make the treatment with MAO-inhibitors an obvious choice. Moclobemide is a novel reversible inhibitor of MAO. We describe a case of severe, resistant depression in a patient suffering from vascular dementia who responded rapidly to a low dose (150 mg/day) of moclobemide.

📜 SIMILAR VOLUMES

A crossover trial of bromocriptine in th

A crossover trial of bromocriptine in the treatment of vascular dementia

✍ Dr. Stephen E. Nadeau; Paul F. Malloy; Michael E. Andrew 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB 👁 1 views

Seven patients with vascular dementia completed an 8month randomized double-blind crossover trial of bromocriptine i n a dosage of u p to 30 mg per day. Patients were assessed using a modified UCLA Parkinson Rating Scale of symptoms and signs, and neuropsychological testing including the Wechsler Ad

Electroconvulsive therapy treatment of d

Electroconvulsive therapy treatment of depression in a patient with adult GM2 gangliosidosis

✍ Dr Perry F. Renshaw; Theodore A. Stern; Charles Welch; Ronald Schouten; Edwin H. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB

Moclobemide and sertraline in the treatm

Moclobemide and sertraline in the treatment of melancholic and nonmelancholic major depression: a comparative study

✍ M. H. Türkçapar; S. Örsel; E. N. Işcan; A. Akdemir; E. Z. Kiliç; M. H. Özbay 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

The objectives of this study were ®rst to compare the responses to moclobemide and sertraline in melancholic and nonmelancholic major depressive patients and secondly to compare the responses of melancholic and nonmelancholic patients in general. Sixty-three patients, with diagnosis of major depress

Prednisone augmentation in treatment-res

Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: A case series

✍ Colin Bouwer; Johann Claassen; Timothy G. Dinan; Charles B. Nemeroff 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Results of treatment changes in patients

Results of treatment changes in patients with apparently drug-resistant chronic epilepsy

✍ Anna L. Luciano; Simon D. Shorvon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

CT measurement of medial temporal lobe a

CT measurement of medial temporal lobe atrophy in Alzheimer's disease, vascular dementia, depression and paraphrenia

✍ Aisling Denihan; Graham Wilson; Conal Cunningham; Davis Coakley; Brian A. Lawlor 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

## Objective: Measurement of medial temporal lobe atrophy (mtl) by computerised tomography (ct) may be a useful adjunct to the diagnosis of ad. the aim of this study was to assess the sensitivity, specificity, predictive values and diagnostic accuracy of ct measurement of mtl thickness for patients